e-Zyvec
Created in 2016
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
30 1,258Activities
Technologies
Entity types
Location
80 Rue du Dr Yersin, 59120 Loos, France
Loos
France
Employees
Scale: 11-50
Estimated: 4
SIREN
823064340Engaged corporates
1
0 0Added in Motherbase
9 months ago
deeptech Value proposition
e-Zyvec services by Polyplus provide tailor-made plasmids that really fit your needs!
e-Zyvec is a French Biotech Start-up founded in 2016 as a spin-off of the University of Lille 1.
We are providing unique solutions in molecular biology to academical or industrial scientists working on research project with genetic engineering applications.
Using our proprietary DNA assembly technology and our in-house developped web application, we can design and produce fully customized gene expression vectors, fitting exactly the requirements of your project.
Getting vectors with e-zyvec is fast, accurate and unrestrictive.
Molecular Biology and Genetic EnginneringOriginal language
e-Zyvec services by Polyplus provide tailor-made plasmids that really fit your needs!
e-Zyvec is a Biotechnology start-up, spinning off the Lille 1 University.
We are offering fully customized solutions for projects requiring complex DNA assembly, such a gene expression vector (plasmids) constructions.
Our offer is dedicated to biologists, both in academy and industry, who need genetic engineering expertise and highly efficient DNA molecules to complete their R&D projects.
Exploiting our proprietary DNA assembly technology, we can assist scientists to design the molecular tools so they will exactly fit their requirements. We will also rapidly produce the desired plasmids thanks to our streamlined production pipeline.
Making vectors with e-Zyvec is fast, accurate and unrestrictive.
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Merck Group Pharmaceutical, Biotechnology, Pharmaceutical Manufacturing | Other 27 Nov 2020 | | |